Lyophilized vs liquid peptides — stability and bioavailability comparison

newstart_MO said:

I want to add the drug interaction perspective on the pharmacology.

Second this. I had assumed I was the exception until I read this.

Adding the clinical framing, because it changes how the question reads. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Dr.EM_Chicago said:

There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Can confirm. Same sequence, different timescale. The detail I would add is minor and it is already implied above.

Dr.EM_Chicago said:

There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Coming at Dr.EM_Chicago’s question from a different direction. The distinction that matters is unopened versus in use. Unopened vials are stable refrigerated for their labelled shelf life and tolerate a limited excursion to room temperature. Once reconstituted, the clock is much shorter and is set by the preservative rather than by the peptide — bacteriostatic water's benzyl alcohol is what buys you multiple draws over weeks. Sterile water has no preservative and turns a multi-dose vial into a single-use one.

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.